Marc Elia

Chairman of the board of Invivyd, a biopharmaceutical company focused on monoclonal antibody platforms, with a background in investment, finance, and health innovation.

Best podcasts with Marc Elia

Ranked by the Snipd community

Feb 12, 2026 • 1h 6min

A Conversation w Invivyd's Marc Elia + Dr. Michael Mina: On Monoclonal Antibodies, Treatment v Prevention, and Giving Patients Options

Marc Elia, Invivyd board chair with finance and biotech experience, and Dr. Michael Mina, epidemiologist and immunologist who led Test-to-Treat, discuss monoclonal antibodies. They cover how monoclonals work across diseases, their roles as treatment versus prevention, using them alongside vaccines, prospects for measles and RSV therapeutics, cost and market challenges, and rebuilding public trust in medical choices.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app